These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9179214)
1. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography. Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214 [TBL] [Abstract][Full Text] [Related]
2. Scintimammography with Tc-99m sestamibi. Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786 [TBL] [Abstract][Full Text] [Related]
3. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166 [TBL] [Abstract][Full Text] [Related]
4. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women. Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536 [TBL] [Abstract][Full Text] [Related]
6. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201 [TBL] [Abstract][Full Text] [Related]
7. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience. Farías-Jimenez J; Rivera A; Carlo VM Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069 [TBL] [Abstract][Full Text] [Related]
8. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions. Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210 [TBL] [Abstract][Full Text] [Related]
9. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168 [TBL] [Abstract][Full Text] [Related]
10. New method for breast cancer detection using TC-99m sestamibi scintimammography. Yuen-Green M; Wasnich R; Caindec-Ranchez S; Davis J Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628 [TBL] [Abstract][Full Text] [Related]
11. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions. Gutfilen B; Fonseca LM J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219 [TBL] [Abstract][Full Text] [Related]
13. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Campeau RJ; Kronemer KA; Sutherland CM Clin Nucl Med; 1992 Dec; 17(12):936-7. PubMed ID: 1334449 [TBL] [Abstract][Full Text] [Related]
14. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography. Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879 [TBL] [Abstract][Full Text] [Related]
15. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results]. Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008 [TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging. Aktolun C J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994 [No Abstract] [Full Text] [Related]
17. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer. Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A Breast J; 2003; 9(4):288-94. PubMed ID: 12846862 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197 [TBL] [Abstract][Full Text] [Related]
20. A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Scopinaro F; Schillaci O; Ussof W; Nordling K; Capoferro R; De Vincentis G; Danieli R; Ierardi M; Picardi V; Tavolaro R; Colella AC Anticancer Res; 1997; 17(3B):1631-4. PubMed ID: 9179208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]